Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,396 | 555 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,194 | 56 | $0 (2024) |
| Amgen Inc. | $1,582 | 41 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,535 | 37 | $0 (2024) |
| Novo Nordisk Inc | $1,275 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,236 | 32 | $0 (2024) |
| Lilly USA, LLC | $1,032 | 43 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $836.42 | 30 | $0 (2024) |
| Abbott Laboratories | $817.35 | 12 | $0 (2024) |
| ABBVIE INC. | $747.75 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $725.17 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,571 | 146 | AstraZeneca Pharmaceuticals LP ($799.73) |
| 2023 | $4,987 | 144 | GlaxoSmithKline, LLC. ($782.57) |
| 2022 | $4,925 | 166 | Novo Nordisk Inc ($456.75) |
| 2021 | $3,913 | 99 | Janssen Pharmaceuticals, Inc ($528.45) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Oncology | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $94.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $126.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 161 | 256 | $72,552 | $21,509 |
| 2022 | 6 | 180 | 259 | $71,556 | $21,815 |
| 2021 | 5 | 176 | 246 | $33,142 | $16,562 |
| 2020 | 7 | 282 | 470 | $58,192 | $22,423 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 150 | $43,800 | $11,583 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $15,794 | $5,914 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 41 | $8,446 | $2,444 | 28.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,512 | $1,568 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 135 | $39,420 | $10,644 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $11,920 | $4,616 | 38.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $6,392 | $2,490 | 39.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 22 | $6,446 | $2,060 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 34 | $7,004 | $1,915 | 27.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $374.00 | $91.08 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 106 | $12,720 | $6,587 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 73 | $13,870 | $5,842 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $4,990 | $3,635 | 72.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 23 | 23 | $782.00 | $382.26 | 48.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $780.00 | $116.05 | 14.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 268 | $43,148 | $15,705 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $7,605 | $4,689 | 61.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 26 | $2,834 | $870.33 | 30.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 57 | 64 | $3,200 | $606.12 | 18.9% |
| 82274 | Stool analysis for blood | Office | 2020 | 18 | 18 | $450.00 | $285.28 | 63.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 11 | 11 | $385.00 | $192.53 | 50.0% |
| 94760 | Measurement of oxygen saturation in blood using ear or finger device | Office | 2020 | 32 | 38 | $570.00 | $74.39 | 13.1% |
About Alfred Liddle, PA
Alfred Liddle, PA is a Physician Assistant healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205813615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alfred Liddle, PA has received a total of $18,396 in payments from pharmaceutical and medical device companies, with $4,571 received in 2024. These payments were reported across 555 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($18,396).
As a Medicare-enrolled provider, Liddle has provided services to 799 Medicare beneficiaries, totaling 1,231 services with total Medicare billing of $82,309. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lincoln, RI
- Active Since 12/28/2005
- Last Updated 10/09/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1205813615
Products in Payments
- JARDIANCE (Drug) $1,276
- FARXIGA (Drug) $1,242
- XARELTO (Drug) $1,236
- Otezla (Drug) $909.03
- NURTEC ODT (Drug) $858.35
- FREESTYLE LIBRE 3 (Device) $693.64
- Ozempic (Drug) $683.14
- TRELEGY ELLIPTA (Drug) $680.90
- HETLIOZ (Drug) $648.80
- BREZTRI (Drug) $575.28
- REXULTI (Drug) $423.86
- AREXVY (Drug) $420.94
- TOUJEO (Biological) $405.34
- Repatha (Biological) $404.04
- NUZYRA (Drug) $380.77
- Rybelsus (Drug) $378.46
- UBRELVY (Drug) $376.29
- ELIQUIS (Drug) $375.67
- ZENPEP (Drug) $370.87
- Kerendia (Drug) $335.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lincoln
Michelle Sitzman, Pa, PA
Physician Assistant — Payments: $98,547
Ms. Stephanie Marlin, Pa-C, PA-C
Physician Assistant — Payments: $29,832
Evelyn Stein
Physician Assistant — Payments: $20,522
Laura Tvrdy, Pa-C, PA-C
Physician Assistant — Payments: $14,244
Jacklynn Kment, Pa-C, PA-C
Physician Assistant — Payments: $9,036
Courtney Mares, Pa-C, PA-C
Physician Assistant — Payments: $8,592